Epigenetics Market is expected to reach US$ 3092.48 million by 2028

The epigenetics market is expected to reach at US$ 3092.48 million by 2028; registering at a CAGR of 14.91% from 2022 to 2028, according to a new research study conducted by The Insight partners

Increasing Prevalence of Cancer Fuels Epigenetics Market Growth 

The report highlights the trends prevailing in the market, along with market drivers and deterrents. Factors driving the market growth are increasing prevalence of cancer, funds & grants provided by government bodies, and declining prices of sequencing. However, high costs of advanced technologies and perception of people for genetic alteration hamper the growth of the market.

Based on product, the global epigenetics market is segmented into kits, reagents, enzymes, instruments & consumables, and bioinformatics tools. In 2022, the kits segment accounted for the highest market share, and it is expected to register a CAGR of 14.3% during the forecast period. Several kits are available in the market for gene expression analysis, MicroRNA analysis, SNP genotyping analysis, and other procedures. The easy-to-use kits are developed for the epigenetic processes to study DNA methylation and histone modifications (deacetylation and acetylation). Mostly, reagents are included in the kit, and each kit contains a detailed procedure that provides sensitive results rapidly. The epigenetic kits allow researchers to perform experiments and analyze epigenetic modifications efficiently and reliably by using antibodies directed against epitope tags or RNA-binding proteins. In epigenetics, highly efficient and fast processing kits are developed to perform the experiments. So, novel toolkits are developed by various companies. For instance, Merck KGaA offered several toolkits, including chromatin immunoprecipitation (ChIP) Kits, bisulfite DNA modification kits, RNA immunoprecipitation (RIP) Kits, for histone modification, DNA methylation, and RNA regulation. The quality control kits are efficient and fast for the preparation of the epigenetic procedures, which drives the market growth in the kits segment.    

Merck KgaA, Thermo Fisher Scientific Inc, Abcam Plc, Agilent Technologies Inc, Qiagen, Bio-Rad Laboratories Inc, Active Motif, Perkin Elmer Inc, New England Biolabs, and Illumina Inc are a few prominent players operating in the epigenetics market.

Companies are launching new and innovative products and services to sustain their position in the epigenetics market. In September 2018, Bio-Rad Laboratories Inc announced the launch of its scATAC-Seq solution, a single-cell assay for transposase-accessible chromatin using sequencing. The epigenomics solution enables genome-wide open chromatin sequencing at single-cell resolution.

Epigenetics Market, by Region, 2022 (%)

The report segments the global epigenetics market as follows:

Based on product, the epigenetics market is segmented into reagents, kits, enzymes, instruments & consumables, and bioinformatics tools. Based on technology, the market is segmented into histone modification, DNA methylation, and others. Based on application, the market is segmented into oncology, cardiovascular diseases, and others. Based on end users, the market is segmented into academic & research institutes, biotechnology & pharmaceutical companies, and contract research organization. By geography, the market is segmented into North America (the US, Canada, and Mexico), Europe (the UK, Germany, France, Italy, Spain, and the Rest of Europe), Asia Pacific (China, Japan, India, Australia, South Korea, and the Rest of Asia Pacific), the Middle East & Africa (the UAE, Saudi Arabia, South Africa, and the Rest of Middle East & Africa), and South & Central America (Brazil, Argentina, and the Rest of South & Central America).

Contact Us
 
Phone: +1-646-491-9876
Email Id: sales@theinsightpartners.com